Anal Carcinoma: Impact of TN Category of Disease on Survival, Disease Relapse, and Colostomy Failure in US Gastrointestinal Intergroup RTOG 98-11 Phase 3 Trial

PURPOSE: The long-term update of US GI Intergroup RTOG 98-11 anal cancer trial found that concurrent chemoradiation (CCRT) with fluorouracil (5-FU) plus mitomycin had a significant impact on disease-free survival (DFS) and overall survival (OS) compared with induction plus concurrent 5-FU plus cispl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gunderson, Leonard L., Moughan, Jennifer, Ajani, Jaffer A., Pedersen, John E., Winter, Kathryn A., Benson, Al B., Thomas, Charles R., Mayer, Robert J., Haddock, Michael G., Rich, Tyvin A., Willett, Christopher G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3938865/
https://ncbi.nlm.nih.gov/pubmed/24035327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2013.07.035
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados